Pharmalittle: Biden supports WTO proposal on Covid-19 vaccine IP – STAT
In a significant move, the U.S. agreed to support a controversial proposal to temporarily waive IP rights for Covid-19 vaccines.
Related Articles
Pharmalittle: We’re reading about a J&J cough syrup, a Pfizer and Moderna patent suit, and more
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps
Colorado lawmakers are abandoning a bill that would have required a new state board — chartered with setting caps for the cost of medicines — to…
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal…
Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s…
Drug shortages reached a record high as 2023 drew to a close
The number of ongoing and active drug shortages in the U.S. stood at 323 during the fourth quarter of last year — the highest figure…
European Parliament votes in favor of updated pharma legislation, prompting mixed reactions
The European Parliament voted to adopt legislation that is supposed to transform the way medicines are brought to market and accessed across much of Europe.
Regeneron accused by Justice Department of manipulating Medicare pricing
The U.S. Department of Justice filed a lawsuit accusing Regeneron Pharmaceuticals of manipulating Medicare pricing by inflating the average sales price
Regeneron accused by Justice Department of manipulating Medicare pricing
The U.S. Department of Justice filed a lawsuit accusing Regeneron Pharmaceuticals of manipulating Medicare pricing by inflating the average sales price
Pharmalittle: We’re reading about a 486% drug price hike, AstraZeneca CEO pay, and more
Is there any circumstance when a 486% percent increase for a medicine might be justified? A small company called Harrow argues the case for an…